Latest period
395M
YoY change
+1.3%
5Y CAGR
+0.4%
Peak year (FY2021)
431M
Latest annual
389M
Shares Outstanding history chart for Moderna (MRNA) from 2016 to 2025
Latest: 389M
Shares Outstanding growth chart for Moderna (MRNA) from 2016 to 2025
Latest: +1.3%
Shares Outstanding history table for Moderna (MRNA) from 2016 to 2025
| FY2025 | 389M | +1.3% | +5M | ||
| FY2024 | 384M | +0.5% | +2M | ||
| FY2023 | 382M | -8.2% | -34M | ||
| FY2022 | 416M | -3.5% | -15M | ||
| FY2021 | 431M | +13.0% | +49.7M | ||
| FY2020 | 381M | +15.3% | +50.5M | ||
| FY2019 | 331M | +0.6% | +2M | ||
| FY2018 | 329M | -12.6% | -47.2M | ||
| FY2017 | 376M | +486.6% | +312M | ||
| FY2016 | 64.1M | — | — |
- FY2025389M+1.3%
- FY2024384M+0.5%
- FY2023382M-8.2%
- FY2022416M-3.5%
- FY2021431M+13.0%
- FY2020381M+15.3%
- FY2019331M+0.6%
- FY2018329M-12.6%
- FY2017376M+486.6%
- FY201664.1M—
Shares Outstanding values are taken from Moderna's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's latest reported diluted shares outstanding is 395M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Moderna (MRNA) most recent annual diluted shares outstanding stands at 389M (2025) – edged up 1.3% year-over-year.
Moderna diluted shares outstanding compound annual growth for the 2020–2025 (5 years) window is +0.4%, sustaining 2 straight years of year-over-year growth.
Moderna diluted shares outstanding declined from 431M in 2021 to 389M in 2025, a 9.7% drawdown.
The record annual diluted shares outstanding stands at 431M, reached in 2021; the historical low of 64.1M was recorded in 2016.
Moderna Shares Outstanding by Year
Moderna Shares Outstanding 2025: 389M
Moderna diluted shares outstanding in 2025 was 389M, edged up 1.3% from 2024.
Moderna Shares Outstanding 2024: 384M
2024's diluted shares outstanding for Moderna came in at 384M, edged up 0.5% from 2023.
Moderna Shares Outstanding 2023: 382M
Moderna posted diluted shares outstanding of 382M in 2023, declined 8.2% below 2022.
Moderna Shares Outstanding 2022: 416M
In 2022, Moderna reported diluted shares outstanding of 416M, edged down 3.5% below 2021.
Moderna Shares Outstanding 2021: 431M
Moderna diluted shares outstanding in 2021 was 431M.
See more financial history for Moderna (MRNA).
Sector peers by Shares Outstanding
Healthcare peers of Moderna (MRNA), ranked by their latest diluted shares outstanding
Frequently asked questions
Moderna (MRNA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.